US$ 23.67
glp 1 binge eating disorder Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? New hope for binge eating
Description
While most current therapies do not directly address the primary drivers of molecular damage, some appear to influence downstream pathways that shape metabolic regulation, inflammatory signaling, and mitochondrial function

Simply put, its a hormone released by the small intestine in response to food arriving in the gut

All-cause mortality was reported in 8 of the 11 studies

Semaglutide is approved for treating type 2 diabetes, but it is increasingly prescribed off-label for weight loss
Enter GLP-1 Receptor Agonists Like Semaglutide and Tirzepatide GLP-1 (Glucagon-Like Peptide-1) receptor agonists were initially developed to treat type 2 diabetes
